Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

July 30, 2009

Perhaps More Lipodystrophy With Sustiva?

by David Evans

People taking a regimen including Sustiva (efavirenz) appeared to have greater limb fat loss and gut fat accumulation than those on Kaletra (liponavir/ritonavir)–based regimen, according to a study presented at the Fifth International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town.

A recently published study—AIDS Clinical Trials Group (ACTG) 1542—found that there was a higher rate of limb fat loss (lipoatrophy) in those on Sustiva than those on Kaletra. However, more people in that study were also on the drugs Zerit (stavudine) and Retrovir (zidovudine), which are most notorious for causing lipoatrophy.

To determine whether the offending drugs were the primary cause of the earlier finding about Sustiva, Jan Van Lunzen, MD, from the University Medical Center Hamburg-Eppendorf, in Germany, and his colleagues studied the medical records of 322 HIV-positive patients in their study. The patients received either Sustiva with two newer nuclesos(t)ide reverse transcriptase inhibitors (NRTIs) or Kaletra with two of the newer NRTIs. The most popular NRTI combination was Viread (tenofovir) with Emtriva (emtricitabine) or Epivir (lamivudine). The second most popular combination was Ziagen (abacavir) with Epivir. The average length of time on the study was 3.5 years.

Van Lunzen’s team found no differences in the efficacy and safety of the two compared drug regimens. They did find, however, that people taking Kaletra had greater elevations in triglycerides. Also, echoing the earlier study, people taking Sustiva had both more loss of limb fat and more gains of fat in their guts.

The authors acknowledge that controlled studies—in which people are randomized and followed without knowing what medications they are taking—would more rigorously determine whether their findings are legitimate or a product of chance or other factors. More objective methods, such as dual energy X-ray absorptiometry (DEXA) scans, for measuring changes in limb fat and fat accumulation in the waist and breasts would also be helpful.

Search: Sustiva, efavirenz, Kaletra, lopinavir/ritonavir, Retrovir, zidovudine, Zerit, stavudine, Viread, tenofovir, Ziagen, abacavir, Emtriva, emtricitabine, Epivir, lamivudine, ACTG 5142, Jan Van Lunzen


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

Dawn, Ventura County, 2009-08-06 00:07:26
I have been on and off Sustiva over the past years since my DX in 1993 and Sustiva DID make my neck and abdomine get larger and legs smaller for sure!!!!! Also had Lactose issues on it as well...

comments 1 - 1 (of 1 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy